Feature Articles

Quality Issues in Pharmaceuticals

Patient safety and wellness has always been at the forefront of the pharmaceutical industry. The consequence of that is the need to maintain high quality standards for pharmaceutical products. This end-goal has to be maintained despite escalating costs and cuts on funding. As a result, pharmaceutical companies are shifting their operations to Asia and the Middle East in an attempt to alleviate the financial pressures in the West. Here, our authors discuss the effects of the current climate in the pharmaceutical industry and how globalization has made its impact - for better or worse. Read More >>

Biosimilars: where we stand today?

As the patent cliff takes effect, comes the rise of biosimilars. They are supposedly the replicas of their brand name innovator pharmaceuticals. Biosimilars are typically priced lower than their brand name counterparts. How will biosimilars fair against the reputation surrounding their brand name competitors? Will biosimilars be able to 'steal' the market share away from branded products? Jack Aurora of Hisun Pharmaceuticals writes about the regulatory landscape of this upcoming industry, what its future might entail and success stories to learn from. Read More >>

• Initiative in Chemical Biology and Therapeutics
  The Department of Biotechnology (DBT) of the Government of India will fund a new initiative for chemical biology and molecular therapeutics in Bangalore at the Institute for Stem Cell Biology and Regenerative Medicine (inStem) in collaboration with the National Centre for Biological Sciences (NCBS), Tata Institute of Fundamental Research. Support from multiple sources including the DBT will provide approximately INR 940M (GBP10.5M) to establish the initiative. Read More >>

• Chinese Science Academy Chief urges seizing on new technological revolution
  The head of China's top scientific think tank has urged the country to seize opportunities presented in the world's new round of technological revolution. Read More >>

• The Chinese Boom - Predictions for 2013
  Three years ago, a thought paper was released predicting that China would become a global leader in the biopharmaceutical market. The idea was met with much protest back then. Today, that is no longer a far-fetched reality. Read More >>

• AB SCIEX and Phenomenex develop food safety solution for India
  AB SCIEX, a global leader in life science analytical technologies, and Phenomenex, a global leader in separation science techniques, announced a new workflow solution specifically tailored for laboratories in India to ensure the safety of spices, teas, fruits, vegetables and other food products for domestic and export markets. Read More >>

• Catching Cancer with Dr. Wang Shutao
  Cancer is a devastating and bewildering disease. It can come about as a result of spontaneous mutation, without any rhyme or reason or as a result of a genetic predisposition of which cancer may develop later in life. Read More >>

• Open Source - The Future of Drug Discovery
  In the world of big pharma, it used to be the case that secrecy paid off big-time. Why risk revealing your drug-discovery pipeline when your competitors may just jump on the band-wagon and eat into your market-share? Read More >>

• International Conference & Exhibition of the Modernization of Chinese Medicine & Health Products (ICMCM)
  Annual Pivotal Event for Global Chinese Medicine Industry
  The 11th edition of the International Conference & Exhibition of the Modernization of Chinese Medicine & Health Products (ICMCM) will welcome more than 100 exhibitors from eight countries and regions. There is also group representation with pavilions from Guizhou, Jilin and Qinghai in the Chinese mainland. Read More >>